Skip to main content

Want a detailed portfolio tracker?

Performance analysis of SANGSTAT MEDICAL (SANG)

Annual Return

Over the past 3 years, SANG has had an average annual return of -0.52%, underperforming the benchmark SPY, which returned +22.77% annual.

Since Nov 8, 2021, SANG has had an average annual return of -28.12%, underperforming the benchmark SPY, which returned +12.66% annual.

202620252024202320222021
-26.79%-29.01%+123.15%-34.04%-71.24%+0.63%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-7.87%-1.08%-16.00%+10.06%-12.76%-0.40%-26.79%
2025-1.95%-22.00%-18.51%+24.93%-1.42%+10.46%-7.67%+8.61%-19.11%+5.70%-0%-2.36%-29.01%
2024-10.32%+35.40%+24.59%-9.73%+32.30%-13.34%+0.40%+5.56%+5.56%+7.06%+2.82%+15.73%+123.15%
2023-5.87%-2.09%-15.82%-5.66%-3.64%+8.18%+21.60%-12.44%-11.95%-17.87%+2.12%+9.97%-34.04%
2022-13.71%-12.69%+12.23%-18.30%-20.08%-9.77%-7.74%+10.96%-38.96%+8.59%-19.46%+5.66%-71.24%
2021+0%+0.63%+0.63%

Drawdown analysis of SANGSTAT MEDICAL (SANG)

The maximum drawdown for the SANG was -87.18%, occurring on Nov 16, 2023. This drawdown has not yet recovered.

The current SANG drawdown is -80.26%.

Since Nov 8, 2021 SANG has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-87.18%Jan 3, 2022471Nov 16, 2023OngoingOngoingOngoing
-17.01%Dec 9, 202111Dec 27, 20215Jan 3, 202216